OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration

Figure 2

Differential expression analysis of OSM in clinicopathological parameters in ccRCC. Differential expression analysis of OSM in (a) pathological grading, (b) T stage, (c) M stage, and (d) total pathological stage. value < 0.05, value < 0.01, and value < 0.001.

(a)

(b)

(c)

(d)